Choroidal Involvement in a Case of Acute Retinal Necrosis

To report choroidal involvement in a case of ARN. A 26-year-old immunocompetent female presented with a history of decreased vision in the right eye for 4 days. The best corrected visual acuity in the right eye was 3/60. Anterior segment examination showed circumciliary congestion, endothelial pigme...

Full description

Saved in:
Bibliographic Details
Published in:Ocular immunology and inflammation 2023-02, Vol.31 (2), p.426-430
Main Authors: Singh, Jayanti, Bhatia, Priyavrat, Sen, Alok, More, Amruta
Format: Article
Language:English
Subjects:
Acute retinal necrosis
Adult
ARN
Choroid
choroiditis in ARN
Female
Fluorescein Angiography
Humans
OCT
Retinal Necrosis Syndrome, Acute - diagnosis
Retinal Necrosis Syndrome, Acute - drug therapy
Retinitis - diagnosis
rpe bump
Valacyclovir - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To report choroidal involvement in a case of ARN. A 26-year-old immunocompetent female presented with a history of decreased vision in the right eye for 4 days. The best corrected visual acuity in the right eye was 3/60. Anterior segment examination showed circumciliary congestion, endothelial pigments, and 1+ cells in the anterior chamber. Fundus examination revealed mild vitritis, disc edema, multifocal patchy retinitis lesions involving the fovea and mid periphery, and arteriolitis. OCT revealed an RPE bump at the macula corroborating with hypocyanacent lesions on indocyanine angiography, which persisted till the late phase, indicating choroidal involvement. The patient was started on oral valacyclovir and oral steroids. Additionally, intravitreal ganciclovir injection was added, leading to a favorable outcome. The final visual acuity post silicone oil removal was 6/60. This is a unique case of ARN having choroidal involvement along with the previously described classical features.
ISSN:0927-3948
1744-5078
DOI:10.1080/09273948.2022.2026416